CASE REPORT
Accepted on 11 Jun 2025
Case report: Dose Adjustment of Orelabrutinib for Managing Central Nervous System Post-Transplant Lymphoproliferative Disorder Following Acute Lymphoblastic Leukemia Transplantation
doi 10.3389/fimmu.2025.1597119
1,309
Total views and downloads
Submit your idea
You will be redirected to our submission process.
CASE REPORT
Accepted on 11 Jun 2025
ORIGINAL RESEARCH
Published on 11 Jun 2025
ORIGINAL RESEARCH
Accepted on 28 May 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.